Surviving
Bevacizumab can slow metastatic kidney cancer; no rise in overall survival.(Clinical Rounds): An article from: Internal Medicine News [H] [T] [M]
Jeff Evans (Digital) International Medical News Group 2003-10-01
Release date: 2005-06-01
Price:
$5.95
$5.95
Answers
Diagnosis was renal cell carcinoma. Right kidney was removed with a radical nephrectomy.
since the affected kidney has already been removed, you have already "upped" your chances of survival. there is now a higher probability of recovering. however, precaution should still be exercised. visit your doctor and have a follow up exam to check wether the surgery was a success and if it was done in time to prevent the spread of the disease. since carcinoma is often caused by too much "bad" carbon in the body, you would do well by not eating "burned meat" that usually happens when cooking in open fire-such as when grilling. good luck!
www.medpagetoday.com Robert A. Figlin, MD, City of Hope, Duarte, Calif. CHICAGO -- In patients with treatment-naive advanced renal cell carcinoma ...
According to Medline Plus Medical Encylopedia, the 5-year survival rate is 60-75%.
My father has stage four renal cell carcinoma. After a radical nephrectomy, it spread to his arm bone, liver and lungs. In a few months it has grown and become very aggressive. He is currently in the hospital because he was having a very difficult time breathing. His skin and the whites of his eyes turned yellow. He is in constant pain, sleeps all the time, is to weak to reposition himself in bed. He has had four blood transfusions while in the hospital, he is being treated as a diabetic with insulin shots. He is on oxygen. His doctor was going to put a shunt in his liver to on block a blockage but after his ultrasound they found that his liver was just full of tumors. He tried a chemo therapy a few months ago that made him ery sick, and now his doctor wants to start another chemo treatment. I never get to see his doctors, they are either in the hospital too early or too late to see. My dad is confused and has a difficult time remebering things. I want to know what are chances that he can survive this? And if he can't why should he try more chemo that is going to make him sicker?? I need answers PLEASE! I just can' stand to see him suffer anymore.
One more chemo and your dad will die very soon. Chemotherapy, together with drug-based treatments, made him worse.
Try natural methods such as systemic enzyme therapy. Please see my reference.
My mother has had cancer for 2 years & a half. Today we found out that she has renal cell carcinoma (RCC). the cancer started in one of her kidney's and spread to her lungs.
she lost weight over the years & is very weak
can someone please tell me how long the survival rate with rcc is?
please help and any other advice would be great
It never serves any good purpose to speculate on life expectancy. All patients have different illness characteristics and respond differently to treatment.
As the previous post suggested, her oncologist is the correct person to discuss her treatment plan and prognosis with.
Best wishes.
1. A possible treatment of acute renal failure is:
A. Long-term dialysis
B. There is no cure; it will become chronic.
C. Short-term dialysis
D. It is always fatal.
2. The five-year survival rate for Adenocarcinoma of the kidney is:
A. 25
B. 50
C. 75
D. 90-100
3. The most common neoplasm of the urinary tract is:
A. Adenocarcinoma of the kidney.
B. Transitional Cell Carcinoma.
C. Basal Cell Carcinoma
D. Malignant Melanoma
4. What age group is most commonly affected by incontinence?
A. Mid-30's
B. Mid-50's
C. Seniors
D. Teenagers
5.Which of the following is not a possible contributor of incontinence?
A. Pregnancy
B. Enlarged prostate
C. Too much to eat
D. Kidney stones
6. Cystitis refers to:
A. any infection of the urinary tract.
B. infection of the urethra.
C. kidney infection.
D. bladder infection.
7. A supplement that might be needed when taking diuretics is:
A. iron.
B. salt.
C. potassium.
D. calcium.
8. Nocturia refers to:
A. frequent urination.
B. urination at night
C. lack of urination.
D. painful urination
LOL...here are your answers..
1. C.
2. Survival rate depends on stage. Overall, it is about 65%, so you pick which one you want to choose 50 or 75%
3. A
4. C
5. Bad question. Answer can be C or D.
6. D
7. C
8. B
Good luck.
Cancer Journal: Latest cancer research Combination versus single ...
Combination therapy for renal cell carcinoma does not improve overall or progression-free survival compared with single therapy using interferon alfa-2a alone. However, the combined regimen might still have a role because it can produce remissions that are of clinically relevant length in some patients. Thus identification of these patients is crucial. These are the conclusions of an article published in an upcoming edition of Renal cell carcinomas account for 2% of all malignant tumours in adults. 30% of patients with renal cell carcinoma present with metastatic disease (secondary tumours), and half of those who apparently have localised disease at diagnosis subsequently develop metastases....
News
Combination therapy did not improve survival for patients with renal cell ...HemOncToday - Feb 15, 2010
Survival was similar between patients with renal cell carcinoma treated with interferon alfa-2a alone or those treated with combination therapy ofMarketWatch (press release) - Feb 17, 2010
Archexin has FDA Orphan drug designation for five different cancer types, including renal cell carcinoma, glioblastoma, pancreatic, stomach and ovarian and morenbsp;raquo;Nature.com (subscription) - Feb 15, 2010
Neoadjuvant targeted therapy can be used in patients with unresectable locally advanced, locally recurrent or metastatic renal cell carcinoma to induce
MedPage Today - Feb 12, 2010
Note that the study was conducted when single-agent interferon alfa-2a was the standard of care for metastatic renal cell carcinoma in Europe.UroToday - Feb 08, 2010
Tumor necrosis is a potential marker of recurrence and survival after surgery for renal cell carcinoma. We determined whether a correlation exists betweenScience Daily (press release) - Feb 05, 2010
quot;Advanced renal cell carcinoma remains a challenging disease, but the outlook for patients has improved in the past year -- including the addition of and morenbsp;raquo;ecancermedicalscience - Feb 11, 2010
Combination therapy for renal cell carcinoma does not improve overall or progression-free survival compared with single therapy using interferon alfa-2a and morenbsp;raquo;